Table 7.
C5adesArg levels and antiβ2-GPI titres in patients before and after (>60 days) treatment with HCQ (6.5 mg/kg/day). * different from before HCQ, p<0.05
| Before HCQ | After HCQ | |||||
|---|---|---|---|---|---|---|
| aβ2GPI (Units) | aCL (Units) | C5a (ng/ml) | aβ2GPI (Units) | aCL (Units) | C5a (ng/ml) | |
| IgG | IgG | |||||
| Patient 8 | 65 | 68 | 132 | 72 | 72 | 45 |
| Patient 9 | 78 | 86 | 156 | 83 | 91 | 65 |
| Patient 10 | 124 | 132 | 97 | 130 | 128 | 22 |
| Patient 11 | 85 | 42 | 123 | 76 | 51 | 31 |
| Patient 12 | 135 | 56 | 198 | 145 | 67 | 39 |
| Mean ± SD | 97±30 | 77±35 | 141±38 | 101±34 | 82±30 | 40±16* |